Is a complete FHTX research report available?

No complete published report is available for Foghorn Therapeutics Inc. (FHTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Foghorn Therapeutics Inc. (FHTX)

NASDAQ: FHTX · USD

$4.74

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FHTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	278.3M
Revenue (ttm)	28.2M
Net income (ttm)	-75.3M
EPS (ttm)	-$1.17
Shares out	58.7M
Volume	173,420
Beta	2.86
Price target	$11.4	+141.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 28.2M
Net income (ttm): -75.3M
EPS (ttm): -$1.17
Market cap: 278.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All FHTX indicators

Market & fundamental data

Available fields

196

Groups with data

Currency

USD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001822462
Company name	Foghorn Therapeutics Inc.
Country	United States
Country code	US
Cusip	344174107
Employees	106
Employees Change	-6%
Employees Change Percent	-5.36
Enterprise value	$136.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-10-23
Isin	US3441741077
Last refreshed	2026-07-31
Market cap	$278.3M
Market cap category	Micro-Cap
Price	$4.74
Price currency	USD
Rev Per Employee	266,264.15x
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	FHTX
Website	https://foghorntx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-27.07%
EV Sales Forward	4.33x
EV/Sales	4.84x
FCF yield	-31.41%
P/S ratio	9.86x
PS Forward	8.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-301.34%
EBITDA Margin	-291.62%
Gross margin	-190.88%
Gross Profit	$-53.9M
Net Income	$-75.3M
Net Income Growth Years	3%
Pretax Margin	-266.88%
Profit Margin	-266.88%
Profit Per Employee	$-710,604
ROA	-21
Roa5y	-18.98
ROCE	-53.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-19.74%
Cagr3y	-19.36%
Cagr5y	-12.8%
EPS Growth Quarters	1
EPS Growth Years	6
Revenue Growth	20.08x
Revenue Growth Q	-45.11x
Revenue Growth Years	1x
Revenue Growth3 Y	11.04x
Revenue Growth5 Y	108.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.12
Assets	$222.2M
Cash	$183.6M
Current Assets	$188.1M
Current Liabilities	$64.4M
Debt	$42M
Equity	$-76.4M
Liabilities	$298.6M
Long Term Assets	$34.1M
Long Term Liabilities	$234.2M
Net Cash	$141.6M
Net Cash By Market Cap	$50.89
Net Cash Growth	-23.74%
Tangible Book Value	$-76.4M
Tangible Book Value Per Share	$-1.3
WACC	17.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.92
Net Working Capital	$-58.1M
Quick ratio	2.85
Working Capital	$123.7M
Working Capital Turnover	$0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.75%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-19.73%
200-day SMA	4.88
3Y total return	-47.57%
50-day SMA	4.59
50-day SMA vs 200-day SMA	50under200
5Y total return	-49.57%
All Time High	28.27
All Time High Change	-83.23%
All Time High Date	2020-12-18
All Time Low	2.7
All Time Low Change	75.56%
All Time Low Date	2024-02-05
ATR	0.35
Beta	2.86
Beta1y	2.08
Beta2y	1.92
Ch YTD	-12.22
High	4.83
High52	6.95
High52 Date	2026-01-13
High52ch	-31.8%
Low	4.61
Low52	3.27
Low52 Date	2025-11-04
Low52ch	44.95%
Ma50ch	3.25%
Price vs 200-day SMA	-2.81%
RSI	44.48
RSI Monthly	46.81
RSI Weekly	49.16
Sharpe ratio	0.03x
Sortino ratio	0.12
Total Return	-7.75%
Tr YTD	-12.22
Tr1m	-2.47%
Tr1w	-6.51%
Tr3m	-0.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	5
Analyst Price Target Top	$11.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.23
Earnings Revenue Estimate	7,971,200x
Earnings Revenue Estimate Growth	5.48x
Operating Income	$-80.8M
Operating margin	-286.2
Price target	$11.44
Price Target Change	$141
Price Target Change Top	$143

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,409,262%
Float Percent	46.68%
Shares Insiders	7.48%
Shares Institutions	36.85%
Shares Out	58,713,922
Shares Qo Q	10.27%
Shares Yo Y	7.75%
Short Float	5.6%
Short Ratio	4.02
Short Shares	2.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-97.5M
Adjusted OCF	-97,487,000
Average Volume	354,338.3x
Bv Per Share	-1.3
CAPEX	$-22,000
Ch1m	-2.47
Ch1w	-6.51
Ch1y	-19.73
Ch3m	-0.42
Ch3y	-47.57
Ch5y	-49.57
Ch6m	-17.85
Change	0%
Change From Open	0
Close	4.74
Days Gap	0
Depreciation Amortization	2,743,000
Dollar Volume	822,010.8
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-85M
EBITDA	$-82.3M
EPS	$-1.17
F Score	2
FCF	$-87.4M
FCF EV Yield	-63.96x
FCF Per Share	$-1.49
Financing CF	50,656,000
Fiscal Year End	December
Founded	2,015
Investing CF	64,920,000
Ipr	-70.38
Iprfo	-75.05
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-11
Ma150	5.02
Ma150ch	-5.63%
Ma20	5.32
Ma20ch	-10.82%
Net CF	28,179,000
Next Earnings Date	2026-08-11
Open	4.74
Optionable	Yes
Position In Range	60
Ppne	32,100,000
Price Date	2026-07-30
Relative Volume	0.49x
Revenue	28,224,000x
SBC By Revenue	35.75x
Share Based Comp	10,090,000
Tr6m	-17.85%
Us State	Massachusetts
Volume	173,420
Z Score	-3.96

Foghorn Therapeutics Inc. (FHTX)

Coverage state: Market snapshot only — no published research

Generate the first FHTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · FHTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FHTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FHTX

Frequently asked questions